Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C9H15NO3S |
Molecular Weight | 217.285 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O
InChI
InChIKey=FAKRSMQSSFJEIM-RQJHMYQMSA-N
InChI=1S/C9H15NO3S/c1-6(5-14)8(11)10-4-2-3-7(10)9(12)13/h6-7,14H,2-5H2,1H3,(H,12,13)/t6-,7+/m1/s1
Molecular Formula | C9H15NO3S |
Molecular Weight | 217.285 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:23:49 UTC 2023
by
admin
on
Fri Dec 15 15:23:49 UTC 2023
|
Record UNII |
9G64RSX1XD
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
C09AA01
Created by
admin on Fri Dec 15 15:23:49 UTC 2023 , Edited by admin on Fri Dec 15 15:23:49 UTC 2023
|
||
|
WHO-ATC |
C09BA01
Created by
admin on Fri Dec 15 15:23:49 UTC 2023 , Edited by admin on Fri Dec 15 15:23:49 UTC 2023
|
||
|
NDF-RT |
N0000000181
Created by
admin on Fri Dec 15 15:23:49 UTC 2023 , Edited by admin on Fri Dec 15 15:23:49 UTC 2023
|
||
|
NDF-RT |
N0000175562
Created by
admin on Fri Dec 15 15:23:49 UTC 2023 , Edited by admin on Fri Dec 15 15:23:49 UTC 2023
|
||
|
WHO-VATC |
QC09AA01
Created by
admin on Fri Dec 15 15:23:49 UTC 2023 , Edited by admin on Fri Dec 15 15:23:49 UTC 2023
|
||
|
WHO-VATC |
QC09BA01
Created by
admin on Fri Dec 15 15:23:49 UTC 2023 , Edited by admin on Fri Dec 15 15:23:49 UTC 2023
|
||
|
NCI_THESAURUS |
C247
Created by
admin on Fri Dec 15 15:23:49 UTC 2023 , Edited by admin on Fri Dec 15 15:23:49 UTC 2023
|
||
|
LIVERTOX |
NBK548504
Created by
admin on Fri Dec 15 15:23:49 UTC 2023 , Edited by admin on Fri Dec 15 15:23:49 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
D002216
Created by
admin on Fri Dec 15 15:23:49 UTC 2023 , Edited by admin on Fri Dec 15 15:23:49 UTC 2023
|
PRIMARY | |||
|
3380
Created by
admin on Fri Dec 15 15:23:49 UTC 2023 , Edited by admin on Fri Dec 15 15:23:49 UTC 2023
|
PRIMARY | |||
|
C340
Created by
admin on Fri Dec 15 15:23:49 UTC 2023 , Edited by admin on Fri Dec 15 15:23:49 UTC 2023
|
PRIMARY | |||
|
1998
Created by
admin on Fri Dec 15 15:23:49 UTC 2023 , Edited by admin on Fri Dec 15 15:23:49 UTC 2023
|
PRIMARY | RxNorm | ||
|
263-607-1
Created by
admin on Fri Dec 15 15:23:49 UTC 2023 , Edited by admin on Fri Dec 15 15:23:49 UTC 2023
|
PRIMARY | |||
|
m3046
Created by
admin on Fri Dec 15 15:23:49 UTC 2023 , Edited by admin on Fri Dec 15 15:23:49 UTC 2023
|
PRIMARY | Merck Index | ||
|
4373
Created by
admin on Fri Dec 15 15:23:49 UTC 2023 , Edited by admin on Fri Dec 15 15:23:49 UTC 2023
|
PRIMARY | |||
|
CHEMBL1560
Created by
admin on Fri Dec 15 15:23:49 UTC 2023 , Edited by admin on Fri Dec 15 15:23:49 UTC 2023
|
PRIMARY | |||
|
CAPTOPRIL
Created by
admin on Fri Dec 15 15:23:49 UTC 2023 , Edited by admin on Fri Dec 15 15:23:49 UTC 2023
|
PRIMARY | |||
|
9G64RSX1XD
Created by
admin on Fri Dec 15 15:23:49 UTC 2023 , Edited by admin on Fri Dec 15 15:23:49 UTC 2023
|
PRIMARY | |||
|
100000092557
Created by
admin on Fri Dec 15 15:23:49 UTC 2023 , Edited by admin on Fri Dec 15 15:23:49 UTC 2023
|
PRIMARY | |||
|
5158
Created by
admin on Fri Dec 15 15:23:49 UTC 2023 , Edited by admin on Fri Dec 15 15:23:49 UTC 2023
|
PRIMARY | |||
|
484
Created by
admin on Fri Dec 15 15:23:49 UTC 2023 , Edited by admin on Fri Dec 15 15:23:49 UTC 2023
|
PRIMARY | |||
|
CAPTOPRIL
Created by
admin on Fri Dec 15 15:23:49 UTC 2023 , Edited by admin on Fri Dec 15 15:23:49 UTC 2023
|
PRIMARY | Description: A white or almost white, crystalline powder. Solubility: Freely soluble in water, dichloromethane R, and methanol R. Category: Cardiovascular agent; angiotensin-converting enzyme inhibitor. Storage: Captopril should be kept in a tightly closed container, protected from light. Additional information: Captopril may exist in different polymorphic forms. Requirement: Captopril contains not less than 98.0% and not more than 102.0% of C9H15NO3S, calculated with reference to the dried substance. | ||
|
757419
Created by
admin on Fri Dec 15 15:23:49 UTC 2023 , Edited by admin on Fri Dec 15 15:23:49 UTC 2023
|
PRIMARY | |||
|
SUB06081MIG
Created by
admin on Fri Dec 15 15:23:49 UTC 2023 , Edited by admin on Fri Dec 15 15:23:49 UTC 2023
|
PRIMARY | |||
|
6527
Created by
admin on Fri Dec 15 15:23:49 UTC 2023 , Edited by admin on Fri Dec 15 15:23:49 UTC 2023
|
PRIMARY | |||
|
9G64RSX1XD
Created by
admin on Fri Dec 15 15:23:49 UTC 2023 , Edited by admin on Fri Dec 15 15:23:49 UTC 2023
|
PRIMARY | |||
|
DB01197
Created by
admin on Fri Dec 15 15:23:49 UTC 2023 , Edited by admin on Fri Dec 15 15:23:49 UTC 2023
|
PRIMARY | |||
|
1091200
Created by
admin on Fri Dec 15 15:23:49 UTC 2023 , Edited by admin on Fri Dec 15 15:23:49 UTC 2023
|
PRIMARY | |||
|
62571-86-2
Created by
admin on Fri Dec 15 15:23:49 UTC 2023 , Edited by admin on Fri Dec 15 15:23:49 UTC 2023
|
PRIMARY | |||
|
DTXSID1037197
Created by
admin on Fri Dec 15 15:23:49 UTC 2023 , Edited by admin on Fri Dec 15 15:23:49 UTC 2023
|
PRIMARY | |||
|
44093
Created by
admin on Fri Dec 15 15:23:49 UTC 2023 , Edited by admin on Fri Dec 15 15:23:49 UTC 2023
|
PRIMARY | |||
|
Captopril
Created by
admin on Fri Dec 15 15:23:49 UTC 2023 , Edited by admin on Fri Dec 15 15:23:49 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (TITRATION)
EP
|
||
|
TRANSPORTER -> SUBSTRATE | |||
|
BINDER->LIGAND |
BINDING
|
||
|
TARGET -> INHIBITOR |
Binding Assay
IC50
|
||
|
TRANSPORTER -> INHIBITOR |
|
||
|
TARGET -> INHIBITOR | |||
|
TRANSPORTER -> SUBSTRATE | |||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (TITRATION)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
IN-VIVO
URINE
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
|
|||
Volume of Distribution | PHARMACOKINETIC |
|
|
|||